Abstract
Initial results from proton spectroscopy performed on the brains of 80 pediatric patients indicate both a research and clinical investigative role for MRS in the future evaluation of pediatric patients. Proton spectroscopy in the evaluation of pediatric brain disease is only in its infancy. However, even though the number of cases that have been studied is not great, its value as a window into in vivo biochemistry is already obvious. The ability to correlate biochemical markers to imaging findings opens up a new era in magnetic resonance research.
Proton spectroscopy remains a research tool, but one that has proven to be of value by adding in vivo biochemical information regarding tissue abnormalities seen and not seen on MRI.
Get full access to this article
View all access options for this article.